000			02360 a2200745 4500
005			20250516205618.0
264		0	_c20140602
008			201406s 0 0 eng d
022			_a1533-4406
024	7		_a10.1056/NEJMoa1402454 _2doi
040			_aNLM _beng _cNLM
100	1		_aAfdhal, Nezam
245	0	0	_aLedipasvir and sofosbuvir for untreated HCV genotype 1 infection. _h[electronic resource]
260			_bThe New England journal of medicine _cMay 2014
300			_a1889-98 p. _bdigital
500			_aPublication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650	0	4	_aAdolescent
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aAntiviral Agents _xadverse effects
650	0	4	_aBenzimidazoles _xadverse effects
650	0	4	_aDrug Administration Schedule
650	0	4	_aDrug Resistance, Viral
650	0	4	_aDrug Therapy, Combination
650	0	4	_aFemale
650	0	4	_aFluorenes _xadverse effects
650	0	4	_aGenotype
650	0	4	_aHepacivirus _xgenetics
650	0	4	_aHepatitis C, Chronic _xdrug therapy
650	0	4	_aHumans
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aRNA, Viral _xblood
650	0	4	_aRibavirin _xadverse effects
650	0	4	_aSofosbuvir
650	0	4	_aUridine Monophosphate _xadverse effects
650	0	4	_aViral Load
650	0	4	_aYoung Adult
700	1		_aZeuzem, Stefan
700	1		_aKwo, Paul
700	1		_aChojkier, Mario
700	1		_aGitlin, Norman
700	1		_aPuoti, Massimo
700	1		_aRomero-Gomez, Manuel
700	1		_aZarski, Jean-Pierre
700	1		_aAgarwal, Kosh
700	1		_aBuggisch, Peter
700	1		_aFoster, Graham R
700	1		_aBräu, Norbert
700	1		_aButi, Maria
700	1		_aJacobson, Ira M
700	1		_aSubramanian, G Mani
700	1		_aDing, Xiao
700	1		_aMo, Hongmei
700	1		_aYang, Jenny C
700	1		_aPang, Phillip S
700	1		_aSymonds, William T
700	1		_aMcHutchison, John G
700	1		_aMuir, Andrew J
700	1		_aMangia, Alessandra
700	1		_aMarcellin, Patrick
773	0		_tThe New England journal of medicine _gvol. 370 _gno. 20 _gp. 1889-98
856	4	0	_uhttps://doi.org/10.1056/NEJMoa1402454 _zAvailable from publisher's website
999			_c23730322 _d23730322